In8Bio is currently undergoing a significant digital transformation to manage its complex clinical-stage biotechnology operations. This involves implementing specialized systems to handle the vast amounts of data generated from their gamma-delta T-cell therapy research and clinical trials. Their transformation strategy focuses on standardizing data capture, ensuring regulatory compliance, and streamlining critical workflows across their scientific and clinical departments.
This ongoing transformation creates specific dependencies on robust data pipelines and integrated systems, making data integrity and system interoperability critical. Risks include data discrepancies between research and clinical systems, potential delays in regulatory submissions, and challenges in maintaining traceability across their highly specialized supply chain. This page will analyze In8Bio's key digital initiatives, identify where operational failures occur, and highlight sales opportunities for relevant technology vendors.
In8Bio Snapshot
Headquarters: New York, NY, United States
Number of employees: 17
Public or private: Public
Business model: B2B
Website: http://www.in8bio.com
In8Bio ICP and Buying Roles
- Biotechnology companies undergoing early-stage clinical trials requiring robust data management and regulatory compliance systems.
- Companies with complex R&D pipelines and critical supply chain needs for novel cell therapies.
Who drives buying decisions
-
Clinical Operations Lead → Manages clinical trial execution and data collection.
-
Head of Research → Oversees lab experiments and data integrity.
-
Head of Regulatory Affairs → Responsible for submissions and compliance.
-
Head of Data Management → Ensures accuracy and consistency of clinical and research data.
-
Head of Supply Chain → Manages specialized material logistics for trials.
-
Chief Technology Officer → Oversees technology adoption and system integration.
Key Digital Transformation Initiatives at In8Bio (At a Glance)
- Clinical Data Management System Adoption: Implementing specialized systems for collecting, managing, and analyzing clinical trial data.
- Electronic Lab Notebook System Deployment: Digitizing and centralizing laboratory experimental data and protocols.
- Regulatory Information Management System Rollout: Standardizing the creation, approval, and submission of regulatory documents to health authorities.
- Clinical Supply Chain System Integration: Connecting manufacturing and logistics systems for cell therapy components and products.
Where In8Bio’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Data Management (CDM) Platforms | Clinical Data Management System Adoption: Data discrepancies occur between trial sites during manual entry. | Clinical Operations Lead, Head of Data Management | Validate clinical trial data automatically against predefined rules across all sites. |
| Clinical Data Management System Adoption: Inconsistent coding standards apply to adverse event reporting. | Clinical Operations Lead, Head of Data Management | Enforce standardized medical coding across all incoming clinical data. | |
| Electronic Lab Notebook (ELN) Solutions | Electronic Lab Notebook System Deployment: Experimental protocols are not consistently followed or recorded. | Head of Research, Lab Manager | Standardize experimental procedure documentation and adherence within the ELN. |
| Electronic Lab Notebook System Deployment: Data transfer from lab instruments to ELN requires manual transcription. | Head of Research, Lab Manager | Directly ingest data from lab equipment into the ELN without manual steps. | |
| Regulatory Information Management (RIM) Systems | Regulatory Information Management System Rollout: Document versions conflict during collaborative authoring. | Head of Regulatory Affairs, Director of Quality Assurance | Manage document versions and access controls for regulatory submissions. |
| Regulatory Information Management System Rollout: Submission package components require manual assembly. | Head of Regulatory Affairs, Director of Quality Assurance | Automate the collation and publishing of regulatory submission dossiers. | |
| Clinical Supply Chain Management (CSCM) Software | Clinical Supply Chain System Integration: Cell therapy material traceability breaks down across external partners. | Head of Supply Chain, Manufacturing Operations Lead | Track and verify material movements across the entire clinical supply chain. |
| Clinical Supply Chain System Integration: Inventory levels for critical components are inconsistent between systems. | Head of Supply Chain, Manufacturing Operations Lead | Synchronize inventory data across manufacturing, logistics, and clinical trial sites. |
Identify when companies like In8Bio are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this In8Bio’s digital transformation unique
In8Bio’s digital transformation is unique due to its specialized focus on gamma-delta T-cell therapies, which involves highly complex research and clinical supply chains. Their approach prioritizes stringent regulatory compliance and precise data integrity for novel biological products. This necessitates systems that not only manage data but also ensure auditability and traceability across preclinical and early-stage clinical trial phases. The company heavily depends on integrating highly specialized scientific data with clinical and regulatory workflows.
In8Bio’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Data Management System Adoption
What the company is doing
Implementing a dedicated Clinical Data Management System (CDMS) to capture, store, and manage data from ongoing Phase 1 clinical trials. The system supports data entry, query management, and reporting for patient safety and efficacy outcomes.
Who owns this
- Clinical Operations Lead
- Head of Data Management
Where It Fails
- Manual data entry from investigator sites introduces transcription errors into the CDMS.
- Discrepancies arise in patient reported outcomes due to varied data capture forms across trial sites.
- Coding for adverse events does not align with standardized medical terminologies before database lock.
- Clinical data quality checks require manual review before data submission to regulatory bodies.
Talk track
Noticed In8Bio is implementing Clinical Data Management Systems for their trials. Been looking at how some biotech teams are automatically validating incoming data to prevent manual errors instead of fixing them downstream, happy to share what we’re seeing.
DT Initiative 2: Electronic Lab Notebook System Deployment
What the company is doing
Deploying an Electronic Lab Notebook (ELN) system to digitally record, manage, and share experimental protocols, results, and observations. The system provides a centralized repository for all preclinical research data, replacing paper notebooks.
Who owns this
- Head of Research
- Lab Manager
Where It Fails
- Manual data transfer from lab instruments to the ELN creates transcription errors and delays.
- Experimental protocols are not consistently applied or documented across different research scientists.
- Cross-referencing experiments requires manual searches across disparate datasets within the ELN.
- Data integrity checks for raw experimental results are performed manually before analysis.
Talk track
Saw In8Bio is deploying Electronic Lab Notebook systems for their research. Been looking at how some biotech teams are directly ingesting instrument data to prevent manual transcription errors instead of relying on manual entry, can share what’s working if useful.
DT Initiative 3: Regulatory Information Management System Rollout
What the company is doing
Rolling out a Regulatory Information Management System (RIMS) to centralize regulatory documents, track submission timelines, and manage communications with health authorities. This system streamlines the process of preparing and submitting regulatory filings.
Who owns this
- Head of Regulatory Affairs
- Director of Quality Assurance
Where It Fails
- Document version control issues arise during collaborative authoring of regulatory filings.
- Submission package assembly requires manual consolidation of fragmented documents from various departments.
- Tracking of regulatory commitments and deadlines is inconsistent across multiple spreadsheets.
- Audit trails for changes to critical regulatory documents are not consistently maintained.
Talk track
Looks like In8Bio is rolling out Regulatory Information Management Systems for submissions. Been seeing teams automate document assembly and version control instead of manual consolidation, happy to share what we’re seeing.
DT Initiative 4: Clinical Supply Chain System Integration
What the company is doing
Integrating a Material Requirements Planning (MRP) module or a specialized system within their ERP to track and manage clinical trial materials and manufacturing components. This system connects manufacturing, logistics, and clinical trial sites.
Who owns this
- Head of Supply Chain
- Manufacturing Operations Lead
Where It Fails
- Inventory discrepancies occur between manufacturing records and clinical site usage reports.
- Material traceability breaks down during transfer between external manufacturing partners and trial sites.
- Cold chain monitoring data is not consistently captured or integrated across different logistics providers.
- Real-time visibility into the location and status of critical cell therapy components is unavailable.
Talk track
Noticed In8Bio is integrating Clinical Supply Chain Systems for their therapies. Been looking at how some biotech teams are tracking specialized materials in real-time across partners instead of relying on periodic updates, can share what’s working if useful.
Who Should Target In8Bio Right Now
This account is relevant for:
- Clinical Data Management (CDM) platform providers
- Electronic Lab Notebook (ELN) software vendors
- Regulatory Information Management (RIM) system providers
- Clinical Supply Chain Management (CSCM) solution providers
- Biotech data integration platform companies
- GxP compliance and validation service providers
Not a fit for:
- Generic enterprise resource planning (ERP) systems without biotech modules
- Broad marketing automation platforms
- General IT infrastructure providers without specialized compliance offerings
- Consumer-facing analytics tools
When In8Bio Is Worth Prioritizing
Prioritize if:
- You sell systems that validate clinical trial data against protocol deviations before database lock.
- You sell platforms that integrate lab instrument output directly into electronic lab notebooks.
- You sell solutions that manage regulatory document version control and automate submission package generation.
- You sell tools that track and verify specialized clinical material movements across fragmented supply chains.
- You sell systems that enforce standardized coding for medical events within clinical data.
Deprioritize if:
- Your solution does not address critical data integrity or compliance challenges in biotech.
- Your product is limited to basic project management without specialized research or clinical features.
- Your offering does not support GxP compliance or audit trail requirements.
Who Can Sell to In8Bio Right Now
Clinical Data Management (CDM) Platforms
Veeva Systems - This company provides cloud-based software for the global life sciences industry, including clinical data management.
Why they are relevant: Inconsistent data coding occurs in clinical trials for In8Bio before regulatory submission. Veeva Clinical Data Management helps enforce standardized data capture and coding across multiple trial sites, reducing discrepancies that block data lock.
Medidata Solutions - This company offers a unified platform for clinical research, including electronic data capture and clinical trial management.
Why they are relevant: Manual validation is required to reconcile patient data between trial sites and the central database. Medidata Rave EDC streamlines data collection and automates validation checks, minimizing manual effort and improving data quality for In8Bio's clinical studies.
Electronic Lab Notebook (ELN) / Laboratory Information Management Systems (LIMS)
Thermo Fisher Scientific (Core ELN) - This company provides laboratory software solutions for managing samples, experiments, and data.
Why they are relevant: Research teams struggle with fragmented experimental records and inconsistent data capture in In8Bio's labs. Core ELN centralizes laboratory data and standardizes experiment workflows, ensuring complete data traceability and compliance for preclinical studies.
Benchling - This company offers an R&D Cloud platform for biotech, including ELN, LIMS, and molecular biology tools.
Why they are relevant: Manual transcription of experimental results from instruments into spreadsheets creates data errors and delays in In8Bio's research. Benchling's ELN integrates directly with lab instruments, preventing transcription errors and accelerating data analysis for novel therapy development.
Regulatory Information Management (RIM) Systems
ArisGlobal - This company provides cloud-based software solutions for drug development, including regulatory affairs and pharmacovigilance.
Why they are relevant: Regulatory document versions conflict during collaborative authoring of critical submission components at In8Bio. ArisGlobal's LifeSphere RIM manages document control and workflows, preventing errors and ensuring compliance for health authority filings.
IQVIA (RIM Solutions) - This company offers a range of technology and analytics solutions for life sciences, including regulatory compliance.
Why they are relevant: Assembling regulatory submission packages for In8Bio requires manual consolidation of documents from disparate sources. IQVIA's RIM solutions automate document aggregation and publishing, reducing manual effort and submission delays.
Clinical Supply Chain Management (CSCM) Software
TraceLink - This company provides a network for pharmaceutical supply chain traceability and compliance.
Why they are relevant: Tracking cell therapy materials from manufacturing to clinical sites is complex, leading to traceability gaps for In8Bio. TraceLink provides end-to-end visibility and verification of clinical supply movements, preventing stockouts and ensuring product integrity.
LogiCell - This company offers specialized supply chain management software for cell and gene therapies.
Why they are relevant: Inventory discrepancies occur between manufacturing and clinical trial sites for critical therapy components at In8Bio. LogiCell synchronizes real-time inventory data across the specialized supply chain, preventing material shortages and optimizing distribution for ongoing trials.
Final Take
In8Bio is actively scaling its clinical research and regulatory compliance processes to advance gamma-delta T-cell therapies. Breakdowns are visible in data integrity across clinical trials, manual lab data transcription, inconsistent regulatory document management, and fragmented clinical supply chain traceability. This account is a strong fit for solutions that enforce data quality, automate specialized scientific workflows, standardize regulatory submissions, and provide real-time visibility across complex biotech operations.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.
See how Pintel.AI works Book a demo